Not to worry! “Making Sense of Anti-Sense Oligo Facility Planning '' is now available on-demand. Brought to you by The Medicine Maker and CRB. Catch Me Up!

The Morphologi^® ID can be used to compare material and chemical properties of Active Pharmaceutical Ingredients (APIs) in a drug product using Morphologically-Directed Raman Spectroscopy (MDRS^®). Read More.

The properties of polymeric excipients can directly affect the clinical efficacy, safety, and quality of a finished pharmaceutical product and are routinely identified as critical quality attributes (CQAs). Read More.

Kuhner TOM provides important online data for microbial, plant cell and animal cell cultures from up to 16 shake flasks in parallel. Kuhner TOM accelerates process developments and facilitates scale-ups. Read More.

Pfizer CentreOne offers commercial manufacturing and has integrated cGMP pilot facilities dedicated to process optimization, clinical drug manufacturing and scale-up tech transfers. Let’s collaborate.

Biopharma manufacturers have been using the same approach to viral safety testing for decades. To meet the needs of next generation bioprocessing, the approach needs to evolve. Read More.

The microbiome field offers huge potential. Find out why experts from across the pharma industry are excited about this emerging science, and how it could lead to new breakthrough medicines. More Information.

Tell us what you think of the ads that appear in The Medicine Maker and you could be in with a chance of winning one of two $100 Amazon gift cards. Take Survey Now!